Retatrutide is not like semaglutide or tirzepatide
Furthermore, as HCPs lack prior experience with muscle-preserving therapies, innovators will need to provide practical education on when and how to use such therapies, likely alongside other AOMs, including diagnostic approaches to identify eligible patient segments in routine practice
Competition is heating up, but few players are directly targeting lean mass preservation as a primary differentiator
Sanofi was not involved in data collection
This is thought to increase muscle strength, number of repetitions, and exercise volume
For example, some Christian denominations believe that tattoos are a blasphemy against the body